TRAIP
Basic information
Region (hg38): 3:49828601-49856574
Links
Phenotypes
GenCC
Source: 
- Seckel syndrome (Supportive), mode of inheritance: AR
- Seckel syndrome 9 (Strong), mode of inheritance: AR
- Seckel syndrome 9 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Seckel syndrome 9 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic; Pulmonary | 26595769 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_provided (128 variants)
- Inborn_genetic_diseases (55 variants)
- Seckel_syndrome_9 (10 variants)
- TRAIP-related_disorder (8 variants)
- not_specified (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRAIP gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005879.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 35 | 37 | ||||
| missense | 68 | 78 | ||||
| nonsense | 7 | |||||
| start loss | 0 | |||||
| frameshift | 7 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 10 | 2 | 73 | 44 | 1 | 
Highest pathogenic variant AF is 0.00008921723
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| TRAIP | protein_coding | protein_coding | ENST00000331456 | 15 | 27974 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 0.0000159 | 0.999 | 125702 | 0 | 46 | 125748 | 0.000183 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.32 | 207 | 268 | 0.773 | 0.0000150 | 3069 | 
| Missense in Polyphen | 48 | 76.122 | 0.63057 | 896 | ||
| Synonymous | 1.75 | 80 | 103 | 0.780 | 0.00000535 | 903 | 
| Loss of Function | 2.79 | 13 | 29.3 | 0.443 | 0.00000151 | 330 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000644 | 0.000644 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.00 | 0.00 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.000194 | 0.000193 | 
| Middle Eastern | 0.00 | 0.00 | 
| South Asian | 0.0000981 | 0.0000980 | 
| Other | 0.000163 | 0.000163 | 
dbNSFP
Source: 
- Function
- FUNCTION: E3 ubiquitin ligase acting as a negative regulator of innate immune signaling. Inhibits activation of NF-kappa-B mediated by TNF. Negatively regulates TLR3/4- and RIG-I-mediated IRF3 activation and subsequent IFNB1 production and cellular antiviral response by promoting 'Lys-48'-linked polyubiquitination of TNK1 leading to its proteasomal degradation (By similarity) (PubMed:22945920). Involved in response to genotoxic lesions during genome replication. Promotes H2AX and RPA2 phosphorylation after replication-associated DNA damage and assists fork progression at UV-induced replication-blocking lesions during S phase (PubMed:26595769). Has also been proposed to play a role in promoting translesion synthesis by mediating the assembly of 'Lys- 63'-linked poly-ubiquitin chains on the Y-family polymerase POLN in order to facilitate bypass of DNA lesions and preserve genomic integrity (PubMed:24553286). The function in translesion synthesis is controversial (PubMed:26595769). {ECO:0000250|UniProtKB:Q8VIG6, ECO:0000269|PubMed:22945920, ECO:0000269|PubMed:24553286, ECO:0000269|PubMed:26595769, ECO:0000303|PubMed:26595769}.;
- Disease
- DISEASE: Seckel syndrome 9 (SCKL9) [MIM:616777]: A form of Seckel syndrome, a rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation. {ECO:0000269|PubMed:26595769}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation (Consensus) 
Recessive Scores
- pRec
- 0.0801
Intolerance Scores
- loftool
- 0.308
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.0760
- hipred
- Y
- hipred_score
- 0.661
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.885
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Traip
- Phenotype
- cellular phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- apoptotic process;signal transduction;cell population proliferation;negative regulation of tumor necrosis factor-mediated signaling pathway;protein ubiquitination;negative regulation of NF-kappaB transcription factor activity;negative regulation of interferon-beta production
- Cellular component
- nucleolus;perinuclear region of cytoplasm
- Molecular function
- protein binding;metal ion binding;ubiquitin protein ligase activity